Arkolith/Insider Trading/ALZN/Form 4

Ault Milton C III

DirectorAlzamend Neuro, Inc. (ALZN) · full profile →Form 4 · filed Oct 8, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$344K
Net Open-Market Flow
-$344K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 7, 2025Conversion(C)100K$2.32$232K126K
Oct 7, 2025Sell(S)57K$2.49$143K69K
Oct 6, 2025Sell(S)82K$2.45$201K26K
Oct 3, 2025Conversion(C)100K$2.32$232K108K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 7, 2025Conversion(C)232$1000.00$232K143
Oct 3, 2025Conversion(C)232$1000.00$232K375

Transaction Codes

C
Conversion of a derivative
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-25-014752) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML